As previously reported, Citi analyst P.J. Juvekar upgraded Corteva to Buy from Neutral, stating that he sees a positive path forward going into 2020 after the company "was hit with a confluence of negative factors" in 2019. In the coming year, Corteva has several products in the pipeline, should see strong growth outside the U.S. and can benefit from multiple productivity programs as a new company on top of merger-related synergies, Juvekar tells investors. He edged his price target on Corteva shares up to $34.50 from $34 on higher expected earnings.